SCHEMBL20722370

SCHEMBL20722370

O=C(O)C1C2CC3CC1CC(c1ccc(Cl)cc1)(C3)C2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 2/20 0.46
HSD11B1 P28845 1/20 0.44
NPC1 O15118 1/20 0.43
LMNA P02545 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
RAB9A P51151 1/20 0.40
MAPT P10636 1/20 0.39
PTGS2 P35354 1/20 0.39
EPHX2 P34913 3/20 0.39
SPHK2 Q9NRA0 3/20 0.39
P2RX7 Q99572 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
GFER P55789 1/20 0.38
SPHK1 Q9NYA1 1/20 0.38
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22084311 0.86 NPC1 (0.44) SERPINE1NPC1LMNAALDH1A1MEN1
SCHEMBL22026948 0.86 NPC1 (0.44) SERPINE1NPC1LMNAALDH1A1MEN1
SCHEMBL22084480 0.86 NPC1 (0.44) SERPINE1NPC1LMNAALDH1A1MEN1
SCHEMBL19149356 0.86 NPC1 (0.43) HSD11B1NPC1LMNAALDH1A1MEN1
SCHEMBL22084145 0.81 HSD11B1 (0.48) HSD11B1NPC1LMNAMEN1KMT2A
SCHEMBL29287205 0.81 HSD11B1 (0.48) HSD11B1NPC1LMNAMEN1KMT2A
SCHEMBL18705090 0.78 LMNA (0.63) SERPINE1HSD11B1NPC1LMNAALDH1A1
SCHEMBL24139616 0.74 NPC1 (0.48) HSD11B1NPC1LMNAALDH1A1MEN1
SCHEMBL19173144 0.74 MEN1 (0.44) HSD11B1NPC1LMNAALDH1A1MEN1
SCHEMBL26366441 0.74 LMNA (0.39) SERPINE1NPC1LMNAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200197407-A1 TARGETING KINASES FOR THE TREATMENT OF CANCER METASTASIS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2020-06-25 US disclosed
EP-3665482-A1 TARGETING KINASES FOR THE TREATMENT OF CANCER METASTASIS Board Of Regents, The University Of Texas System (US) 2020-06-17 EP disclosed
WO-2019033041-A1 TARGETING KINASES FOR THE TREATMENT OF CANCER METASTASIS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-02-14 WO disclosed